Evolution of Allergy Testing and the Psychological Impact of False-positive Test Results

Thursday, 8 October
8:00-9:30 PDT | 11:00-12:30 EDT | 17:00-18:30 CEST | 19:00-20:30 GST

Join Professors Mario Morais-Almeida, Ignacio J Ansotegui, Chrissie Jones, and Alessandro Fiocchi for this deep dive into molecular allergy diagnosis. Attendees will gain insights into the advances in molecular diagnostics for allergy testing and participate in a live Q&A session with the presenters.

• Discover how advancements in molecular diagnostic testing have improved the identification of clinically relevant allergens and addressed the issue of cross-reactive carbohydrate determinants (CCDs) interference, leading to better patient care.
  
• Explore the benefits of component testing over whole-allergen extracts and learn about the implication of newly available components on the diagnosis and treatment of our patients.
  
• Understand how a false-positive allergy test result can trigger lasting psychological, behavioral, and family-system changes.
  
• Recognize the mechanisms that link diagnostic uncertainty to reduced quality of life for patients and caregivers and identify practical strategies clinicians can use to support patients through a diagnostic revision.
  
• Examine how molecular allergy diagnostics can improve our understanding and management of allergy to foods of animal origin, moving beyond simply establishing whether a patient is sensitized.